ConductScience.org, home
SALL4: spalt like transcription factor 4
API referenceFor AI assistants

Gene · 57167

Papers3,058

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

81 to 100 of 3,058

Download this page as JSON
TitleJournalYearPMIDFound bySource
Primary Mediastinal Malignant Melanoma Presenting With Pleural Effusion: A Case Report.Cancer Rep (Hoboken)202641629220PubTator, text miningPubMed
<p>Unveiling sex differences in pancreatic ductal adenocarcinoma: Current evidence and future directions (Review)</p>.Int J Oncol202641543183PubTator, text miningPubMed
Sustained Remission following Lung Resection of Isolated Pulmonary Stage III Epithelioid Trophoblastic Tumor: A Case Report.Case Rep Oncol202641536782PubTator, text miningPubMed
Composite Wilms Tumor and Renal Cell Carcinoma: A Comprehensive Clinicopathologic, Immunohistochemical, and Molecular Study of 18 Tumors Highlighting an Uncommon Pediatric Renal Entity.Am J Surg Pathol202641527366PubTator, text miningPubMed
Establishment and characterization of a testicular yolk sac tumor PDX model.Clin Transl Oncol202641525035PubTator, text miningPubMed
Developmental toxicology profile of the IRAK4 degrader KT-474.Toxicol Sci202641385308PubTator, text miningPubMed
Germ cell immunoprofile and KIT exon 17 mutation guide rectification of seminoma misclassified as epithelioid gastrointestinal stromal tumor: A case report.Biomed Rep202641356390PubTator, text miningPubMed
Analysis of gene mutation spectrum for early-onset high myopia based on whole-exome sequencing.Br J Ophthalmol202641344850PubTator, text miningPubMed
Molecular profiling of hepatoid adenocarcinoma and adenocarcinoma with enteroblastic differentiation.Surg Oncol202641232140PubTator, text miningPubMed
Cytologic Findings of Cholangioblastic Variant of Intrahepatic Cholangiocarcinoma: A Rare Variant and Cytologic Pitfall.Diagn Cytopathol202641194440PubTator, text miningPubMed
Construction of CD163-knockout induced pluripotent stem cells using reprogramming technology.Theriogenology202641138636PubTator, text miningPubMed
Targeting SALL4 with an HLA Class I-Restricted TCR for Cancer Immunotherapy.Cancer Immunol Res202641114529PubTator, text miningPubMed
Exploring the Therapeutic Potential of Dedifferentiated Fat Progenitors (DFATs) in Comparison To the Adipose Derived Stem/Stromal Cells (ASCs).Stem Cell Rev Rep202641108454PubTator, text miningPubMed
SOX2 Is the Most Sensitive Biomarker in Testicular and Gynecologic Embryonic-type Neuroectodermal Tumors (ENT) Based on a Comprehensive Evaluation of Biomarker Expression.Am J Surg Pathol202640922405PubTator, text miningPubMed
Intraventricular mass in a 49-year-old male.Brain Pathol202640610013PubTator, text miningPubMed
[Clinical Characteristics and Prognosis Analysis of Thoracic SMARCA4-deficient Undifferentiated Tumor versus SMARCA4-deficient Non-small Cell Lung Cancer].Zhongguo Fei Ai Za Zhi202541777060PubTator, text miningPubMed
CT ventriculographic identification and neuroendoscopic treatment of acquired hydrocephalus due to cerebral aqueduct lesions: a two-case report.Front Oncol202541716711PubTator, text miningPubMed
Gastric Adenocarcinoma With Enteroblastic Differentiation Presenting as Lung Nodules: A Diagnostic Dilemma.J Community Hosp Intern Med Perspect202541658026PubTator, text miningPubMed
A Histological Conundrum With a Distinctive Biochemical Marker: A Case Report of Primary Pulmonary Choriocarcinoma.Cureus202541625888PubTator, text miningPubMed
Cardiac Tamponade As the Initial Presentation of a Thymic Neuroendocrine Tumour: A Case Report.CJC Open202541542134PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Previous pageNext page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/57167/papers?page=5

API referenceFor AI assistants